Institutional Investors Expand Holdings in Altria, Amgen, and PepsiCo Amid Dividend Hikes
Key Facts
Reflecting growing institutional confidence in defensive stocks with high yields, recent filings reveal a strategic expansion by Stephens Inc. AR in its core positions. The firm increased its stake in Altria Group by 8.6%, bringing its total holding value to $17.7 million, and raised its position in Amgen by 8.6% to 114,544 shares valued at approximately $40.6 million. Simultaneously, the firm significantly bolstered its consumer staples exposure by purchasing an additional 39,516 shares of PepsiCo, representing a 29.5% increase in its stake.
This institutional accumulation is supported by robust financial performance and attractive shareholder returns; PepsiCo recently raised its quarterly dividend to $1.48 per share following a beat on both revenue and EPS estimates. For context, peer performance remains strong as Coca-Cola reported an 11% increase in organic revenues in its latest fiscal report per market data. These moves suggest that large-scale investors are prioritizing companies with proven pricing power and the ability to sustain dividend growth amid macroeconomic uncertainty.
As of the close on July 2, 2026, MO was priced at $72.71 and AMGN at $374.15, with PEP showing strength following its dividend announcement. Investors should watch for upcoming ex-dividend dates and consumer sentiment data in the economic calendar to gauge the continued momentum of value-oriented sectors. The focus remains on whether these large-cap entities can maintain their operating margins as global economic conditions evolve.